On November 16, Applied Therapeutics Inc Appointed Les Funtleyder As Chief Financial Officer, Principal Financial Officer Effective November 20, 2023
Portfolio Pulse from Benzinga Newsdesk
Applied Therapeutics Inc has appointed Les Funtleyder as the new Chief Financial Officer and Principal Financial Officer, effective November 20, 2023, according to an SEC filing.
November 17, 2023 | 9:18 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Les Funtleyder's appointment as CFO of Applied Therapeutics Inc may bring new financial strategies and potentially positive changes to the company's financial management.
The appointment of a new CFO is often viewed as a significant change in a company's executive team, which can lead to new financial strategies and potentially improve financial performance. Investors may react positively to this change, expecting that Les Funtleyder will contribute positively to the company's financial health.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100